Annals of Diagnostic Pathology
Volume 11, Issue 3 , Pages 182-189 , June 2007

Frontotemporal clear cell meningioma. Report of 3 cases

  • Martha Lilia Tena-Suck, MD

      Affiliations

    • Neuropathology Department, National Institute of Neurology and Neurosurgery, Mexico, DF 14269, Mexico
    • Corresponding Author InformationCorresponding author. Tel.: +52 5 56063822x2008.
    • ,
  • Citlaltepelt Salinas-Lara, MS, Sci, MD

      Affiliations

    • Neuropathology Department, National Institute of Neurology and Neurosurgery, Mexico, DF 14269, Mexico
    • ,
  • Celedonio Gómez, BSc

      Affiliations

    • Department of Pathology, National Cancer Institute of Mexico City, Mexico City, DF 14269, Mexico
    • ,
  • Daniel Rembao Bojórquez, MD

      Affiliations

    • Neuropathology Department, National Institute of Neurology and Neurosurgery, Mexico, DF 14269, Mexico

References 

  1. Louis DN, Scheithauer BW, Budka H, von Deimling A, Kepes JJ. In:  Keihues P,  Cavenee WK editor. Tumors of the nervous system, pathology and genetics. World Health Organization classification of tumors. IARC Press Lyon; 2000;p. 244–246
  2. Kuzeyli K, Cakir E, Usul H, Karaarslan G, Kadir Reis A, Temiz C, et al. Clear cell meningioma: case report and literature review. J Clin Neurosci. 2003;10:264–266
  3. Jallo GL, Kthbauer KF, Silverira M, Epstien FJ. Intraspinal clear cell meningiomas: diagnosis and management; report of two cases. Neurosurgery. 2001;48:218–222
  4. Yu KB, Lim MK, Kim HJ, Suh CH, Park HC, Kim EY, et al. Clear-cell meningioma: CT and MR imaging findings in two cases involving the spinal canal and cerebellopontine angle. Korean J Radiol. 2002;3:125–129
  5. Liu PI, Liu GC, Tsai KB, Lin CL, Hsu JS. Intraspinal clear cell meningiomas; a case report and review of the literature. Surg Neurol. 2005;3:285–289
  6. Boet R, Ng HK, Kumta S, Chan LC, Chiu KW, Poon WS. Lumbosacral clear-cell meningiomas treated with subtotal resection and radiotherapy. J Clin Neurosci. 2004;11:432–436
  7. Zorludemir S, Scheithauer BW, Hirose T. Clear cells meningiomas; a clinicopathologic study of potentially aggressive variant of meningiomas. Am J Surg pathol. 1995;19:493–505
  8. Pimentel J, Fernandez A, Pinto AE, Fonseca I, Moura Núñez JF, Lobo Antunez J. Clear cells meningioma variant and clinical aggressiveness. Clin Neuropathol. 1998;17:141–146
  9. Pinz M, Patts S, Mitrovics T, Vervos-Navarro J. Clear cell meningioma; report of spinal case. Gen diagn Pathol. 1996;141:261–269
  10. Manivel JC, Sung JM. Pathology of meningiomas. Pathol Annu. 1990;2:159–192
  11. Jellinger K, Slowitk F. Histological subtypes and prognostic problems in meningioma. J Neurol. 1975;208:279–298
  12. Wahab M, Al-Azzawi F. Meningioma and hormonal influences. Climacteric. 2003;6:285–292
  13. Taddei GL, Caldarella A, Raspollini MR, Taddei A, Buccoliero AM. Estrogen and progesterone receptors in meningiomas: immunohistochemical (Mib-1, p53) and clinico-morphological correlations. Pathologica. 2002;94:10–15
  14. Blankenstein MA, Verheijen FM, Jacobs JM, Donker TH, van Duijnhoven MW, Thijssen JH. Occurrence, regulation, and significance of progesterone receptors in human meningioma. Steroids. 2000;65:795–800
  15. Went PT, Lugli A, Meier S, Bundi M, Mirlacher M, Sauter G, et al. Frequent EpCam protein expression in human carcinomas. Hum Pathol. 2004;35:122–128
  16. Osta WA, Chen Ym Mikhitarian K, Mitras M, Salen M, Hannun YA, Cole DJ, et al. EpCAM is overexpressed in breast cancer and it is a potential target for breast cancer Gene therapy. Cancer Res. 2004;64:5818–5824
  17. Das A, Tan WL, Smith DR. Expression of the inhibitor of apoptosis protein survivin in benign meningiomas. Cancer Lett. 2003;193:217–223
  18. Shono T, Inamura T, Torisu M, Suzuki SO, Fukui M. Vascular endothelial growth factor and malignant transformation of a meningioma: case report. Neurol Res. 2000;22:189–193
  19. Kuratsu Jl, Seto H, Kochi M, Ushio Y. Expression of PDGF, PDGF-receptor, EGF-receptor and sex hormone receptors on meningioma. Acta Neurochir (Wien). 1994;131:289–293
  20. Lin CC, Kenyon L, Hyslop T, Hammond E, Andrews DW, Curran WJ, et al. Cyclooxygenase-2 (COX-2) expression in human meningioma as a function of tumor grade. Am J Clin Oncol. 2003;26:98–102
  21. Forseen SE, Potti A, Koka V, Koch M, Fraiman G, Levitt R. Identification and relationship of HER-2/neu overexpression to short-term mortality in primary malignant brain tumors. Anticancer Res. 2002;22:1599–1602
  22. Potti A, Panwalkar A, Langness E, Sholes K, Tendulkar K, Chittajalu S, et al. Role of Her-2/neu overexpression and clinical features at presentation as predictive factors in meningiomas. Am J Clin Oncol. 2004;27:452–466
  23. Hakin-Smith V, Battersby RD, Maltby EL, Timperley WR, Royds JA. Elevated p53 expression in benign meningiomas protects against recurrence and may be indicative of senescence. Neuropathol Appl Neurobiol. 2001;27:40–49
  24. Honda M, Bara S, Kaminogo M, Tamaru N, Nagata I. Rapidly growing microcystic meningioma of the middle fossa floor. Neurol med Chir (Tokyo). 2005;45:311–314
  25. Fouladi M, Helton K, Dalton J, Gilger E, Gajjar A, Merchant T, et al. Clear cell ependymoma: a clinicopathologic and radiographic analysis of 10 patients. Cancer. 2003;98:2232–2244
  26. Koperek O, Gelpi E, Birner P, Haberler C, Budka H, Hainfellner JA. Value and limits of immunohistochemistry in differential diagnosis of clear cell primary brain tumors. Acta Neuropathol (Berl). 2004;108:24–30
  27. Cimatti M, Salvati M, Caroli E, Frati A, Brogna C, Gagliardi FM. Extremely delayed cerebral metastasis from renal carcinoma: report of four cases and critical analysis of the literature. Tumori. 2004;90:342–344
  28. Klos KJ, O'Neill BP. Brain metastases. Neurologist. 2004;10:31–46
  29. Koperek O, Gelpi E, Birner P, Haberler C, Budka H, Hainfellner JA. Value and limits of immunohistochemistry in differential diagnosis of clear cell primary brain tumors. Acta Neuropathol (Berl). 2004;108:24–30
  30. Sell M, Sampaolo S, Di Lorio G, Theallier A. Chordomas: a histological and immunohistochemical study of cases with and without recurrent tumors. Clin Neuropathol. 2004;23:277–285
  31. Houdouin L, Polivka M, Henegar C, Blanquet A, Delalande O, Mikol J. Pituitary germinoma and lymphocytic hypophysitis: a pitfall. Report of two cases. Ann Pathol. 2003;23:349–354
  32. Dundar E, Arslantas A, Acikalin MF, Tel E. Cerebellar metastasis from clear cell sarcoma of the kidney. A case report with immunohistochemistry. J Neurosurg Sci. 2001;45:228–231
  33. Korshunov A, Golanov A. Pleomorphic xanthoastrocytomas: immunohistochemistry, grading and clinico-pathologic correlations. An analysis of 34 cases from a single institute. J Neurooncol. 2001;5:63–72
  34. Withers T, Klevansky A, Weinstein SR. Lipomeningiomas: case report and review of the literature. J Clin Neurosci. 2003;10:712–714
  35. Ohnisti T, Watanabe S. Histogenesis of clear cell hidradenoma; immunohistochemical study of keratin expression. J Cutan Pathol. 1997;24:30–36

PII: S1092-9134(06)00034-7

doi: 10.1016/j.anndiagpath.2006.03.007

Annals of Diagnostic Pathology
Volume 11, Issue 3 , Pages 182-189 , June 2007

Article Tools

* Image Usage & Resolution